ClinicalTrials.gg
CompletedNCT04140747TRAMICUpdated Aug 27, 2024

Transfer of Strictly Anaerobe Microbes From Mother to Child

An observational study in Microbial Colonization, sponsored by Medical University of Graz. Completed at 1 site in Austria. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-27.

Sponsored by Medical University of Graz · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
94
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This study aims to investigate the changes in the microbiota at different body sites in late pregnancy, in comparison with non-pregnant women, with particular emphasis on archaea, and to identify possible maternal-to-child transfer routes for acquisition of strictly anaerobic microorganisms by analyzing the gut microbiota of new born infants (delivered vaginally or by C-section).

Read the detailed description

The investigators hypothesize that changes occur in the microbial community during pregnancy in different body sites (vagina, oral etc.) and that the main source of these microorganisms is the mother for vaginally born infants, while C-section born infants acquire most of the anaerobic microbial communities from other sources rather than mother's vaginal and gut microbiota, such as the environment.

Specific Research Objectives will be:

  1. To investigate diversity of archaea in the vagina of healthy women in the context with community state types (CSTs), and compare vaginal microbiome in pregnant with non-pregnant healthy women.
  2. To identify the presence of archaea in different body sites (oral, gut) or body fluids (amniotic fluid, urine, human milk) within the perinatal microbial communities.
  3. To investigate the presence of archaea in the infant's first-days-of-life intestinal community, and to identify the sources of these microorganisms by using source tracking approach.
  4. To investigate Human Milk Oligosaccharides (HMOs) in maternal (serum, saliva, urine, breast milk) or intrauterine sources (amniotic fluid) as potential modifiers of the microbial communities in these sites.
  5. To analyze associations of maternal/ intrauterine HMOs with infant HMOs and microbiota (meconium and infant stool) in order to investigate vertical transmission of microbiota to the infant.
02

Conditions studied

  • Microbial Colonization
03

In context

Communicable Diseases

4,448 studies on the registry are indexed under Communicable Diseases; 514 are open to participants now.

This study's enrollment of 94 is below the median of 240 across 1,501 observational studies indexed under Communicable Diseases.

Browse Communicable Diseases studies →

Lead sponsor

Medical University of Graz is the lead sponsor of 470 studies on the registry; 98 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy non-pregnant women and women with an ongoing healthy pregnancy. 3 groups will be formed: non-pregnant women (n=30), women delivering vaginally (n=30) and women undergoing C-section (n=30).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy women
  • pregnant women: delivery at term (gestational age 37-42); contractions or rupture of membrane no longer than 12h before admission to hospital

Exclusion criteria

Exclusion Criteria:

  • bacterial/ fungal infections
  • use of antibiotics/ probiotics in past 3 months
  • fetal anomalies
  • multiple pregnancies
  • diabetes type 1, 2, gestational diabetes
  • hypertension, preeclampsia/HELLP
  • HIV ( human immunodeficiency virus), HCV (Hepatitis C)
  • drug abuse, smoking
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
94 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • non-pregnant women

    Samples will be collected from 30 healthy, non-pregnant women in the reproductive age: blood, urine, stool, saliva, oral swabs, vaginal swabs

  • pregnant women delivering vaginally

    From 30 healthy, pregnant women giving vaginal birth, samples will be collected shortly before, during and after birth from maternal and newborn sites: maternal blood, urine, stool, saliva, oral swabs, vaginal swabs; cord blood, colostrum, meconium, infant oral swabs

  • pregnant women undergoing C-section

    From 30 healthy, pregnant women giving vaginal birth, samples will be collected shortly before, during and after birth from maternal and newborn sites: maternal blood, urine, stool, saliva, oral swabs, vaginal swabs; amniotic fluid, cord blood, colostrum, meconium, infant oral swabs

06

What researchers measure

Primary outcomes

  1. maternal microbiome

    difference between non-pregnant and pregnant women

    Time frame: 2020-2023

  2. fetal/neonatal microbiome

    difference between vaginal and C-section born infants

    Time frame: 2020-2023

Secondary outcomes

  1. Human milk oligosaccharides

    associations of HMOs with maternal/infant microbiome

    Time frame: 2020-2023

07

Study locations

1 site
  • Medical University of Graz
    Graz, 8043, Austria
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04140747
Responsible party
Sponsor
First posted
Oct 28, 2019
Start date
Oct 7, 2016
Primary completion
Jan 2022
Completion
Jan 2022
Last update
Aug 27, 2024

Study contacts

Evelyn Jantscher-Krenn, PhD
principal investigator · Medical University of Graz
Christine Moissl-Eichinger, PhD
principal investigator · Medical University of Graz

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion